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 1 
Summary 2 
Severe fever-with-thrombocytopenia syndrome virus (SFTSV) is an emerging tick-3 
borne pathogen causing significant morbidity and mortality in Asia. NSs protein of 4 
SFTSV is known to perturb type I interferon (IFN) induction and signalling, but the 5 
mechanism remains to be fully understood. Here, we showed the suppression of both 6 
type I and type III IFN signalling by SFTSV NSs protein mediated through inhibition 7 
of STAT1 phosphorylation and activation. Infection with live SFTSV or expression of 8 
NSs potently suppressed IFN-stimulated genes but not NF-κB activation. NSs was 9 
capable of counteracting the activity of IFN-α1, IFN-β, IFN-λ1 and IFN-λ1. 10 
Mechanistically, NSs associated with STAT1 and STAT2, mitigated IFN-β-induced 11 
phosphorylation of STAT1 at serine 727, and reduced the expression and activity of 12 
STAT1 protein in IFN-β-treated cells, resulting in the inhibition of STAT1 and STAT2 13 
recruitment to IFN-stimulated promoters. Taken together, SFTSV NSs protein is an 14 
IFN antagonist that suppresses phosphorylation and activation of STAT1.  15 
 16 
Keywords: severe fever-with-thrombocytopenia syndrome virus (SFTSV); 17 
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Severe fever-with-thrombocytopenia syndrome virus (SFTSV) is a novel phlebovirus 1 
first isolated in 2009 in China, where it causes a tick-borne zoonosis in humans and 2 
domestic animals (Yu et al., 2011; Niu et al., 2013). Human patients are presented with 3 
acute fever, thrombocytopenia, leukocytopenia as well as gastrointestinal and joint 4 
symptoms. In a small subset of severe cases the disease progresses rapidly to multiorgan 5 
failure, hemorrhage and death, with the case fatality rate ranging from 2% to 15% (Liu 6 
et al., 2014; Li, 2015). Whereas the majority of patients are farmers who live in wooded 7 
upland areas and work in the fields, a few clusters of cases and human-to-human 8 
transmission through direct contact with blood or respiratory secretions have also been 9 
reported (Bao et al., 2011; Gai et al., 2012). Human infection of SFTSV has been 10 
identified retrospectively in Korea and Japan (Kim et al., 2013; Takahashi et al., 2014). 11 
SFTSV and related viruses have also been isolated in ticks collected in Korea and 12 
Australia (Yun et al., 2014; Wang et al., 2014). Furthermore, Heartland virus, another 13 
tick-borne phlebovirus sharing 60-73% amino acid sequence homology with SFTSV, 14 
has been shown to be etiologically associated with an SFTS-like severe disease in US 15 
(McMullan et al., 2012; Muehlenbachs et al., 2014). Thus, SFTSV and closely related 16 
human pathogens are distributed widely.   17 
 18 
SFTSV belongs to the Phlebovirus genus of the Bunyaviridae family. Similar to other 19 
bunyaviruses, SFTSV contains a tripartite single-stranded RNA genome of negative 20 
sense (Walter & Barr, 2011). Whereas the L segment encodes viral polymerase, the M 21 
segment codes for envelope glycoproteins Gc and Gn. Nucleocapsid and nonstructural 22 
protein NSs are expressed in opposite directions from the ambisense S segment.  23 
Characterization of viral virulence factors might shed light on the mechanism of severe 24 
diseases caused by SFTSV. As a major virulence factor, NSs proteins from many 25 
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bunyaviruses are capable of antagonizing interferon (IFN) response. Among them NSs 1 
protein from Rift Valley fever virus (RVFV) is one of the most extensively studied 2 
(Ikegami & Makino, 2011). However, the mechanism of NSs-mediated immune 3 
evasion varies from one to another bunyavirus (Walter & Barr, 2011).  4 
 5 
Innate immune response is triggered by the sensing of pathogen-associated molecular 6 
patterns by host pattern recognition receptors (Habjan & Pichlmair, 2015). Subsequent 7 
activation of the signalling cascades leads to the induction of type I and type III IFNs 8 
by transcription factors IRF3 and IRF7. The binding of type I and type III IFNs to their 9 
receptors results in auto-phosphorylation and activation of the receptor-associated 10 
kinases TYK2 and JAK1, which regulate the activation of STAT1 and STAT2. 11 
Together with IRF9, homodimers or heterodimers of phosphorylated STAT1 and 12 
STAT2 form the ISGF3 complex, which translocates into the nucleus, binds to specific 13 
IFN-stimulated response elements (ISREs) present in the promoters of IFN-stimulated 14 
genes (ISGs), and activates their transcription (Schneider et al., 2014). Viruses have 15 
evolved various IFN antagonists to counteract IFN induction and signalling at all steps 16 
(Randall & Goodbourn, 2008; Hoffmann et al., 2015).  17 
 18 
During the course of SFTSV infection in humans, IFNs are almost undetectable in the 19 
blood (Qu et al., 2012), indicating the suppression of IFN production. Consistent with 20 
this, SFTSV NSs protein has been shown to suppress type I IFN production through the 21 
interaction with RIG-I, TRIM25 as well as IRF3 kinases TBK1 and IKK, leading to 22 
their sequestration in virus-induced cytoplasmic subdomains separated from 23 
mitochondria (Ning et al., 2014; Qu et al., 2012; Santiago et al., 2014; Wu et al., 2014). 24 
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In addition, SFTSV NSs has recently been found to perturb type I IFN signalling by 1 
interacting with STAT2 and thus retaining STAT1 and STAT2 in the cytoplasm (Ning 2 
et al., 2015). However, mechanistic details of NSs-induced suppression of IFN 3 
production and signalling remain controversial and thus merit further investigations. 4 
 5 
Although SFTSV NSs has been shown to inhibit both NF-B and IRF3 transcription 6 
factors (Qu et al., 2012), we noted the upregulated expression of many NF-B-7 
regulated cytokines such as interleukin 6 (IL6), IL8 and tumour necrosis factor  (TNF-8 
) in humans and primates infected with SFTSV (Sun et al., 2012; Deng et al., 2012; 9 
Jin et al., 2015). To resolve this discrepancy, we compared the impact of NSs 10 
expression on Sendai virus-induced activation of IFN- promoter and canonical B 11 
elements. Dual luciferase assays were performed (Chan et al., 2010; Kok et al., 2011), 12 
with reporter constructs driven respectively by IFN- promoter (IFN-Luc) and by five 13 
tandem copies of canonical B element (B-Luc). It is known that the activation of 14 
IFN- promoter by Sendai virus is mediated primarily through IRF3 (Lin et al., 1998). 15 
Notably, VP35 from Ebola virus and NSs from RVFV, which are well characterized 16 
suppressors of type I IFN induction (Billecocq et al., 2004; Cardenas et al., 2006; 17 
Ikegami et al., 2009; Kalveram et al., 2013), were capable of impeding Sendai virus-18 
induced activation of IFN- promoter in our assay (Fig. 1a, bars 4 and 5 versus 2). As 19 
expected, VP35 and IB super-repressor also ablated NF-B activation (Fig. 1b, bars 20 
4 and 5 versus 2). In contrast, SFTSV NSs suppressed the activation of IFN- promoter 21 
by Sendai virus (Fig. 1a, bar 3 versus 2), but had no influence on its activation of NF-22 
B (Fig. 1b, bar 3 versus 2). A similar pattern was also observed when we used MAVS 23 
to induce the activation of IFN- promoter and NF-B (Fig. 1b, d). In addition, SFTSV 24 
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NSs had no inhibitory effect on Sendai virus- or TNF--induced activation of NF-B 1 
in HeLa or HepG2 cells (Fig. 1e, f). Thus, SFTSV NSs preferentially suppressed IRF3 2 
but not NF-B activity in our setting. These results were at odds with a previous report 3 
(Qu et al., 2012) but might be more compatible with the overproduction of NF-B-4 
induced cytokines in SFTSV-infected cells (Jin et al., 2015). Further studies are 5 
required to determine whether NF-B is activated by SFTSV. On the other hand, the 6 
inability of SFTSV NSs to suppress NF-B activation also implicated that it unlikely 7 
suppressed general transcription or translation. Thus, its suppression of type I IFN 8 
production is specific.   9 
 10 
We next examined the effect of SFTSV NSs protein on type I and type III IFN 11 
signalling using a luciferase reporter driven by ISREs (ISRE-Luc). ISRE-dependent 12 
reporter expression was potently induced in HEK293 cells treated with IFN-, IFN-1 13 
or IFN-2. This activity was largely ablated when SFTSV NSs was expressed (Fig. 1g, 14 
h and Fig. S1a; bar 3 versus 2). The suppressive activity of SFTSV NSs was more 15 
pronounced than that of RVFV NSs (Fig. 1g, h and Fig. S1a; bar 3 versus 4). In light 16 
of this, we went on to verify the suppression of IFN signalling in SFTSV-infected cells. 17 
We chose THP-1 cells, which were further induced to differentiate into macrophages, 18 
for the infection experiment, because macrophages are highly responsive to IFN 19 
treatment and they are also thought to play an important role in SFTSV pathogenesis 20 
(Jin et al., 2012). mRNA expression of five selected ISGs, namely MX1, OAS1, ISG15, 21 
ISG56 and STAT1, was assessed by RT-qPCR as described (Tang et al., 2013; Yuen et 22 
al., 2015). Primer sequences are presented in the supplementary material. All five ISGs 23 
were strongly induced by IFN-1 and SFTSV individually (Fig. 1i-l and Fig. S1b, bars 24 
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2 and 3 versus 1). However, the steady-state mRNA levels of the ISGs did not increase 1 
further but decreased in IFN-1-treated and SFTSV-infected cells (Fig. 1i-l and Fig. 2 
S1b, bar 4 versus 2). Similar results were also obtained from IFN-1-treated SFTSV-3 
infected HEK293T cells (Fig. 1m, n and Fig. S1c), indicating that the effect was not 4 
cell type-specific. Although SFTSV replication was inhibited by IFN-1, reasonably 5 
high copy numbers of viral RNA were still detected in IFN-1-treated THP-1 cells (Fig. 6 
S2). The inability of the remaining SFTSV to augment or at least maintain the ISG-7 
inducing activity of IFN-1 suggested that SFTSV might antagonize IFN-1. In 8 
contrast to previous findings (Ning et al., 2014), in our setting SFTSV was capable of 9 
inducing ISG expression more substantially in THP-1 and HEK293T cells. It remains 10 
to be determined whether the use of different SFTSV strains in the two studies might 11 
account for the different results.    12 
 13 
In addition to representative ISGs, we also examined the expression of two 14 
proinflammatory cytokines IL8 and CCL5 in infected cells. Both IL8 and CCL5 are 15 
well-characterized NF-B target genes (Kunsch & Rosen, 1993; Wickremasinghe et 16 
al., 2004). Their mRNA expression levels remained unchanged in SFTSV-infected 17 
THP-1 cells stimulated with lipopolysaccharide (LPS), a strong activator of NF-B 18 
(Fig. 1o, p). Furthermore, expression of SFTSV NSs did not affect phorbol ester-19 
induced nuclear translocation of p65 subunit of NF-B in HeLa cells (Fig. 2a, panel 2; 20 
NSs-expressing versus NSs-non-expressing cells). Thus, our results from luciferase 21 
assays (Fig. 1b, d, e, f), RT-qPCR (Fig. 1o, p) and confocal staining (Fig. 2a) 22 
consistently indicated no suppression of NF-B activation by SFTSV NSs.  23 
 24 
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The suppression of type I and III IFN signalling by SFTSV NSs protein prompted us to 1 
investigate further whether it might affect the stability and function of STAT1 and 2 
STAT2. Although SFTSV NSs has recently been shown to interact with STAT2 but not 3 
STAT1 (Ning et al., 2015), we would like to re-examine this issue in our experimental 4 
setting. We noted that STAT1, STAT2 and an active form of STAT1 phosphorylated 5 
at S727 appeared in the nucleus of IFN--treated HeLa cells.  However, only weak and 6 
cytoplasmic staining of STAT1 and STAT2 was observed in NSs-expressing cells (Fig. 7 
2b, c, panel 2, NSs-expressing versus NSs-non-expressing cells). In addition, nuclear 8 
staining of STAT1 phosphorylated at S727 was not seen in the presence of NSs (Fig. 9 
2d). This suggested that NSs might exert an inhibitory effect on STAT1 and STAT2 10 
activation. To shed further light on this, co-immunoprecipitation was performed as 11 
described (Ng et al., 2011; Tang et al., 2014). STAT1 and STAT2 were detected in the 12 
NSs-containing immunoprecipitate (Fig. 3a, lane 2 versus 1). Although NSs might 13 
indirectly interact with STAT2 through STAT1, our results were also consistent with 14 
the model that NSs could interact with both STAT1 and STAT2.  15 
 16 
Since other viral IFN-antagonizing proteins such as simian virus 5 V protein are known 17 
to induce ubiquitination and degradation of STAT1 (Precious et al., 2005), we asked 18 
whether SFTSV NSs might also affect the steady-state levels of STAT1. Western blot 19 
analysis of whole cell extracts was carried out as described (Chin et al., 2005; Chun et 20 
al., 2013) and the results indicated that NSs had no influence on STAT1 protein stability 21 
ambiently in HEK293 cells (Fig. 3b, lane 2 versus 1). However, when STAT1 was 22 
activated by IFN-β, the steady-state amounts of STAT1 in NSs-expressing cells 23 
detected over a time course of 24 hours were diminished consistently (Fig. 3b, lane 4 24 
versus 3, lane 6 versus 5, and lane 8 versus 7). The inhibitory effect of NSs was not 25 
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seen when cells were treated with actinomycin D, an inhibitor of RNA polymerase II 1 
(Fig. 3c, lane 5 versus 4). These results suggested that NSs-induced inhibition likely 2 
occurs at the level of STAT1 transcription. As previously shown by others (Wong et 3 
al., 2002) and in Fig. 1l, n, STAT1 is an ISG. The abrogation of the inhibitory effect of 4 
NSs on STAT1 expression in IFN-β-treated cells by actinomycin D suggested that NSs 5 
might suppress type I IFN-induced activation of STAT1 transcription.  6 
 7 
Exactly how SFTSV NSs modulates phosphorylation and activation of STAT1 remains 8 
elusive. IFNs induce STAT1 phosphorylation at two major sites Y701 and S727. Both 9 
modifications are required for full activation of STAT1 (Wen et al., 1995; Takaoka et 10 
al., 1999). To determine the impact of NSs expression on STAT1 phosphorylation, 11 
Western blotting was performed with phospho-specific antibodies. Whereas NSs had 12 
no influence on Y701 phosphorylation of STAT1, it exerted a suppressive effect on 13 
S727 phosphorylation (Fig. 3d, lane 3 versus 2). To shed light on where this inhibition 14 
by NSs might occur, we collected and analyzed the cytosolic and nuclear fractions. NSs 15 
and STAT1 were detected in both fractions. In addition, STAT1 with phospho-S727 16 
was also found in reduced levels in both the cytosol and the nucleus (Fig. 3d, lane 6 17 
versus 5, and lane 9 versus 8). Although a primarily cytoplasmic staining of NSs was 18 
observed in HeLa cells (Fig. 2), we cannot rule out that a subset of NSs might enter the 19 
nucleus. Biochemical fractionation is a more sensitive method. On the other hand, the 20 
nuclear localization of NSs might not be observed by confocal microscopy when 21 
cytoplasmic NSs is more prominent. Considered together with the absence of STAT1 22 
with phospho-S727 in NSs-expressing HeLa cells (Fig. 2d), our results were generally 23 
compatible with the notion that NSs might suppress STAT1 phosphorylation at S727 24 
in both the cytoplasm and the nucleus. These data do not support the model in which 25 
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NSs functions solely to sequester STAT1 and STAT2 in the cytoplasm (Ning et al., 1 
2015).    2 
 3 
Whether SFTSV NSs affects STAT1 and STAT2 recruitment to the ISREs in ISG 4 
promoters has not yet been characterized. To address this, we performed chromatin 5 
immunoprecipitation (ChIP) assay as described (Tang et al., 2014). Primers for qPCR 6 
analysis of ISREs in IFI6 and ADAR1 promoters are presented in the supplementary 7 
material. IFI6 and ADAR1 are two representative ISGs (Samuel, 2011; Schneider et 8 
al., 2014). They were chosen in the ChIP-qPCR assay only for technical reasons. We 9 
observed that IFN--induced recruitment of STAT1 and STAT2 to the ISREs in both 10 
IFI6 and ADAR1 promoters was impeded in NSs-expressing HEK293 cells (Fig. S3a, 11 
b, bar 5 versus 3, and bar 6 versus 4). Consistent with this, mRNA levels of IFI6 and 12 
ADAR1 were dampened in the presence of NSs (Fig. S3c, d, bar 3 versus 2). Hence, 13 
SFTSV NSs inhibits IFI6 and ADAR1 expression by preventing the recruitment of 14 
STAT1 and STAT2 proteins to their promoters. 15 
 16 
Several salient points concerning SFTSV NSs-dependent perturbation of IFN 17 
production and signalling emerged in our study. First, we provided evidence for 18 
differential modulation of IRF3 and NF-B by NSs (Fig. 1a-f, i-p and Fig. 2). Second, 19 
we characterized the suppression of type III IFN signalling by NSs (Fig. 1h). Third, we 20 
demonstrated the interaction of NSs with STAT1 (Fig. 3a), the inhibition of IFN--21 
induced STAT1 expression and phosphorylation at S727 but not Y701 by NSs (Fig. 2d 22 
and Fig. 3b-d). Finally, we documented the reduced recruitment of STAT1 and STAT2 23 
to the IRSEs in ISG promoters in NSs-expressing cells (Fig. S3). Because NSs-deficient 24 
11 
 
viruses might be developed as attenuated SFTSV vaccines and IFNs could be tested as 1 
antivirals against SFTSV infection, our work also has implications in the design and 2 
development of SFTSV vaccines and antivirals. 3 
  4 
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Figure Legends 1 
Fig 1. SFTSV NSs suppresses IFN induction and signalling. (a-h) HEK293 cells 2 
expressing the indicated proteins and reporter were infected with 100 hemagglutinating 3 
units/ml of Sendai virus (SENV; a, b, e), transfected with 200 ng/ml of MAVS 4 
expression vector (c, d) or treated with TNF- (10 ng/ml, f), IFN-β (1000 U/ml 5 
purchased from PBL; g) or IFN-λ1 (100 ng/ml from Peprotech; h) for 24 hours. NSs 6 
from Hb29 strain of SFTSV was cloned into pVR1012 expression vector and 200 ng/ml 7 
of this plasmid was used to transfect cells. Dual luciferase assay was performed. Results 8 
represent means ± SD (n = 3). S-NSs: SFTSV NSs. VP35: Ebola virus VP35. R-NSs: 9 
RVFV NSs. IB-sr: IB super-repressor with SA mutations at positions 32 and 36 10 
(EMD Millipore). The difference between groups 2 and 3 in b was statistically not 11 
significant (n.s.) by Student’s t test (p = 0.22). (i-p) SFTSV suppression of IFN-1 12 
signalling. THP-1 cells were treated with 100 nM of phorbol 12-myristate 12-acetate 13 
for 72 hours to induce the differentiation into macrophages. HEK293T cells and 14 
induced THP-1 cells were then either mock-infected or infected with Hb29 strain of 15 
SFTSV at 1000 TCID50/ml. At 24 hours post infection, cells were either mock-treated 16 
or treated with 10 ng/ml of IFN-α1 or 100 ng/ml of LPS for an additional 16 hours. 17 
mRNA levels of the indicated ISGs were measured by RT-qPCR. Results represent 18 
means ± SD (n = 3). Differences between selected groups were highlighted with 19 
asterisks and statistically assessed by Student’s t test. The p values are 0.018 (i), 0.0009 20 
(j), 0.040 (k), 0.008 (l), 0.025 (m), 0.003 (n), 0.49 (o) and 0.39 (p).   21 
 22 
Fig. 2. Influence of SFTSV NSs on NF-B and STAT1 activation. (a) HeLa cells were 23 
transfected with an expression vector for HA-tagged NSs protein for 48 hours. Cells 24 
20 
 
were stimulated with 40 nM of phorbol 12-myristate 12-acetate for 30 minutes and then 1 
stained for HA and p65. The NSs- (green) and p65-specific (red) fluorescent signals 2 
were merged in panel 3. (b-d) HA-tagged NSs was expressed in HeLa cells for 48 hours. 3 
Cells were treated with IFN-β (1000 U/ml) for 30 minutes and then stained for HA 4 
(green) and STAT1, STAT2 or phospho-S727 STAT1 (red). Nuclear morphology (blue) 5 
was visualized with 4′,6-diamidine-2′-phenylindole dihydrochloride (DAPI). Different 6 
fluorescent signals were merged in panel 4. Arrows point to NSs-expressing cells, 7 
whereas NSs-non-expressing cells in the same field are highlighted by arrowheads. Bar, 8 
20 m.   9 
 10 
Fig. 3. Interaction of SFTSV NSs with STAT1 and STAT2. (a) Immunoprecipitation 11 
(IP). HEK293 cells were either mock-transfected or transfected with an expression 12 
vector for HA-tagged NSs. Cell lysates were collected and subjected to precipitation 13 
with mouse anti-HA antibody. Precipitates and cell lysates (input) were analyzed by 14 
Western blotting with antibodies against the indicated proteins. All blots were exposed 15 
for 3 minutes. Rabbit polyclonal anti-STAT1 and anti-STAT2 antibodies were 16 
purchased from Santa-Cruz. Similar results were also obtained for V5-tagged NSs. (b, 17 
c) Steady-state levels of STAT1 protein in NSs-expressing HEK293 cells treated with 18 
IFN-β (1000 U/ml). Relative levels of STAT1 protein normalized to -actin (STAT1/-19 
actin) are determined by densitometry and indicated below the panel. Some cells were 20 
treated with of 5 g/ml of actinomycin D (ActD) for 6 hours before harvest. (d) NSs 21 
inhibits STAT1 phosphorylation at S727. HEK293 cells were treated with IFN-β (1000 22 
U/ml) for 24 hours. Whole cell extracts (WCE) as well as cytosolic and nuclear 23 
fractions were prepared and probed for the indicated proteins. Rabbit polyclonal 24 
21 
 
phospho-specific antibodies recognizing phospho-Y701 (Y701p) and phospho-S727 1 
(S727p) of STAT1 were purchased from Cell Signalling. Cell fractionation was 2 
performed as described (Schreiber et al., 1989). Relative levels of STAT1 S727p 3 
protein normalized to total STAT1 and either glyceraldehyde-3-phosphate 4 
dehydrogenase (GAPDH) or lamin C (rel. S727p) are indicated below the panels. 5 
 6 
 7 



Table S1. Primers used in this study 
Primer Sequence 
ISG56-F 5-GCAGCCAAGTTTTACCGAAG-3 
ISG56-R 5-GCCTTTCTCCGAAGTTTCCT-3 
ISG15-F 5-GACCTGACGGTGAAGATGCT-3 
ISG15-R 5-GAAGGTCAGCCAGAACAGGT-3 
MX1-F 5-CTACACACCGTGACGGATATG-3 
MX1-R 5-CGAGCTGGATTGGAAAGCCC-3 
STAT1-F 5-CATCTTCTCTGGCGACAG-3 
STA1-R 5-CAGTAAGATGCATGATGCCC-3 
OAS1-F 5-CATCCGCCTAGTCAAGCACTG-3 
OAS1-R 5-CACCACCCAAGTTTCCTGTAG-3 
IL8-F 5-TCTGCAGCTCTGTGTGAAGGTGCAGTT-3 
IL8-R 5-AACCCTCTGCACCCAGTTTTCCT-3 
CCL5-F 5-GCATCTGCCT CCCCATATT-3 
CCL5-R 5-AGCACTTGCC ACTGGTGTAG-3 
IFI6-F 5-TAAGAAAAAGTGCTCGGAGAGCTC-3 
IFI6-R 5-CCGACGGCCATGAAGGT-3 
ADAR1-F 5-GCTCTCCGTGTCTTGATTGG-3 
ADAR1-R 5-CTGCCAGTGAGAGGGAGTGT-3 
GAPDH-F1 5-GGAGCGAGATCCCTCCAAAAT-3 
GAPDH-R1 5-GGCTGTTGTCATACTTCTCATGG-3 
GAPDH-F2 5-ACCACAGTCCATGCCATCAC-3 
GAPDH-R2 5-TCCACCACCCTGTTGCTGTA-3 
qChIP-IFI6-F 5-GCAGGCAGCACACAAATG-3 
qChIP-IFI6-R 5-CAATCCCTGTCGGAGTTTCT-3 
qChIP-ADAR1-F 5-AAGCGTGGCGCAAGATTT-3 
qChIP-ADAR1-R 5-GATGGCTCCGGTTCAATTT-3 
 
 
 
 
 
  
 
 
 
Fig S1. SFTSV NSs suppresses IFN-λ2 signalling and ISG56 induction. (a) Suppression of IFN-
λ2 signalling by SFTSV-NSs. HEK293 cells transfected with ISRE-Luc reporter were treated with 
IFN-λ2 (100 ng/ml from PBL) for 24 hours. Dual luciferase assay was performed. Results 
represent means ± SD (n = 3). S-NSs: SFTSV NSs. R-NSs: RVFV NSs. (b, c) Phorbol 12-myristate 
12-acetate-induced THP-1 cells and HEK293T cells were mock-infected or infected with SFTSV. 
Cells were then mock-treated or treated with 10 ng/ml of IFN-α1 at 24 hours post infection. Levels 
of ISG56 mRNA were analysed by RT-qPCR. Results represent means ± SD (n = 3). Differences 
between the selected groups were highlighted with asterisks and statistically assessed by Student’s 
t test. The p values are 0.005 (b) and 0.007 (c). 
 
Fig.  S2. RT-qPCR analysis of SFTSV RNA segments. Copy numbers of L, M and S segments in 
infected and IFN-1-treated THP-1 cells were calculated as described (Jin et al., 2012). 
 
 
Fig. S3. SFTSV NSs inhibits ISG expression by impeding STAT1 and STAT2 
recruitment. (a, b) STAT1 and STAT2 recruitment to the ISREs in IFI6 and ADAR1 
promoters in IFN--treated HEK293 cells was blunted when NSs was overexpressed. 
ChIP was performed with anti-STAT1 and anti-STAT2. The STAT-bound ISREs were 
analyzed by qPCR. Expression of SFTSV N protein had no influence on STAT 
recruitment (data not shown). AU: arbitrary unit. (c, d) Verification of mRNA 
expression. Levels of IFI6 and ADAR1 mRNA in NSs-expressing and IFN--treated 
HEK293 cells were analyzed by RT-qPCR. The difference between bars 2 and 3 in d 
(p = 0.0027; highlighted with ) was statistically significant by Student’s t test. 
